24
Views
8
CrossRef citations to date
0
Altmetric
Case Report

Marked effect and steroid-sparing ability of anakinra on a patient with refractory adult-onset Still’s disease

, , , , , & show all
Pages 200-204 | Received 07 Oct 2009, Accepted 02 Nov 2009, Published online: 02 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Dae Hyun Yoo. (2017) Treatment of adult-onset still’s disease: up to date. Expert Review of Clinical Immunology 13:9, pages 849-866.
Read now

Articles from other publishers (7)

Serena Colafrancesco, Maria Manara, Alessandra Bortoluzzi, Teodora Serban, Gerolamo Bianchi, Luca Cantarini, Francesco Ciccia, Lorenzo Dagna, Marcello Govoni, Carlomaurizio Montecucco, Roberta Priori, Angelo Ravelli, Paolo Sfriso & Luigi Sinigaglia. (2019) Management of adult-onset Still’s disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts. Arthritis Research & Therapy 21:1.
Crossref
Guido Junge, June Mason & Eugen Feist. (2017) Adult onset Still’s disease—The evidence that anti-interleukin-1 treatment is effective and well-tolerated (a comprehensive literature review). Seminars in Arthritis and Rheumatism 47:2, pages 295-302.
Crossref
Giuseppe Lopalco, Luca Cantarini, Antonio Vitale, Florenzo Iannone, Maria Grazia Anelli, Laura Andreozzi, Giovanni Lapadula, Mauro Galeazzi & Donato Rigante. (2015) Interleukin-1 as a Common Denominator from Autoinflammatory to Autoimmune Disorders: Premises, Perils, and Perspectives. Mediators of Inflammation 2015, pages 1-21.
Crossref
Charles Anthony Dinarello. (2014) An Expanding Role for Interleukin-1 Blockade from Gout to Cancer. Molecular Medicine 20:S1, pages S43-S58.
Crossref
Charles A. Dinarello & Jos W.M. van der Meer. (2013) Treating inflammation by blocking interleukin-1 in humans. Seminars in Immunology 25:6, pages 469-484.
Crossref
R Goldbach-Mansky. (2012) Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1. Clinical and Experimental Immunology 167:3, pages 391-404.
Crossref
I. Kötter & G. Horneff. (2010) IL-1-AntagonistenIL-1 antagonists. Zeitschrift für Rheumatologie 69:7, pages 581-593.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.